Jaguar Animal Health 2017 Investor Presentation Napo Merger

Jaguar Animal Health investor presentation dated February 20, 2017, disclosing the company's intended merger with Napo Pharmaceuticals and outlining product pipeline including Mytesi, Canalevia, Equilevia, and Neonorm Calf. The presentation details commercial launch timelines and the anticipated combined company's market opportunities in animal health pharmaceuticals.